Poster Poster Program Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Baseline PET Radiomics for Non-Invasive Risk Stratification In Hodgkin Lymphoma

Abstract
Purpose

Although most patients with Hodgkin lymphoma (HL) are cured with chemotherapy with or without immunotherapy, a subset fails to respond to first-line therapy. Baseline clinical factors alone do not reliably identify nonresponders. Baseline PET radiomic features may provide complementary prognostic information. We developed an automated radiomics pipeline to extract PET features and evaluate their association with clinical outcomes.

Methods

We identified 205 patients with HL with available tissue and baseline PET/CT imaging, comprising a testing cohort (n = 87) and an independent validation cohort (n = 118). A total of 1,316 radiomic features per patient were extracted using an automated PyRadiomics-based pipeline. In the testing cohort, feature selection was performed using a Lasso-Cox proportional hazards model to identify features with non-zero coefficients, followed by minimum redundancy maximum relevance ranking to prioritize features based on relevance and redundancy. Model performance was evaluated using progression-free survival analysis, time-dependent area under the curve (AUC), and concordance index (C-index). Feature-selection stability and generalizability were assessed using 5-fold cross-validation.

Results

Lasso-Cox selection identified 28 features (p < 0.0001), from which the top 9 features achieved strong prognostic performance (C-index = 0.77). Using a less stringent threshold (p < 0.001), 72 candidate features were identified, with the top 6 features achieving comparable discrimination (C-index = 0.77). Survival analyses demonstrated clear risk stratification, with low-risk patients exhibiting excellent long-term progression-free survival. Time-dependent AUC analysis showed improved performance for models using the p < 0.001 threshold. In 5-fold cross-validation, the 6-feature model demonstrated greater stability and superior performance (C-index = 0.78) compared with the 9-feature model (C-index = 0.71), with one feature consistently selected across both models.

Conclusion

Baseline PET/CT radiomic features show strong potential for non-invasive risk stratification in HL and may capture biologically relevant tumor microenvironment information. A six-feature model demonstrated improved stability and prognostic performance.

People

Related

Similar sessions

Poster Poster Program
Jul 19 · 07:00
Adverse Events in Targeted Radionuclide Therapy

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

Harrison L. Agordzo
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Development of a Web-Based Theranostic Workflow Management Tool

To develop a Web-Based Theranostic Workflow Management Tool (TWMT) to efficiently manage Theranostic program in the department of radiation oncology (RadOnc).

Ling Zhuang, PhD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Epidseg-Net:the Multi-Modal Fusion Framework Based on Drr Guidance In Radiotherapy Is Used for Precise Segmentation of Epid Lung Targets

The proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture featu...

Huang Qian Qianjia, M.Eng
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested